Morphine is Still the Standard Opioid in the Treatment of Cancer Pain
-
- SHIMOYAMA Naohito
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- NAKATA Wakako
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- MURAKAMI Satoshi
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- TAKAHASHI Hidenori
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- NAKAYAMA Rika
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- SHUTOH Mariko
- Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
-
- SHIMOYAMA Megumi
- Department of Autonomic Physiology, Chiba University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- モルヒネは現在でもがん性とう痛治療におけるスタンダードである
Abstract
Management of pain in cancer patients according to the WHO ladder using morphine is still the standard in treating cancer pain, even after both oxycontin® and fentanyl patch became available in Japan. One reason is that rescue opioids other than morphine are not available. Immediate opioids are useful not only in treating breakthrough pain, but also in assessing whether the cancer pain is refractory to opioids or not. Although opioid rotation is sometimes performed to control side effects, it should be used only after appropriate side effect treatment. If the side effects are well controlled, side effect control with other opioids is much easier.
Journal
-
- THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
-
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 25 (5), 526-532, 2005
THE JAPAN SOCIETY FOR CLINICAL ANESTHESIA
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679736642304
-
- NII Article ID
- 130004449523
-
- ISSN
- 13499149
- 02854945
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed